MSB vs PEB

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

MSB

MESOBLAST FPO [MSB]

46LOW

PEB

PACIFIC ED FPO NZX [PEB]

46LOW

Score Breakdown

MSB PEB
Technical
70
55
Catalyst
82
51
Sentiment
50
50
Fundamental
78
26
Momentum
60
67
Risk Gate
40
40

Key Metrics

MSB Metric PEB
$3.0BMarket Cap$298.0M
3.8MAvg Volume (20d)31K
+8.4%Short Interest+0.1%
$3.31052-Week High$0.265
$1.63052-Week Low$0.085
+0.8%Daily Change+0.0%
$2.370Entry Price$0.240
-18.2%ROE-194.7%
-144.3%Profit Margin-275.0%

Active Signals

MSB Signals

●MACD momentum is picking up steam
●Stochastic is stretched into overbought — could need a breather
●Pressing against the upper Bollinger Band — extended and may need to cool off
●Trading above both moving averages — the trend is your friend here
●On a tear — up 17.3% over the last 5 days
●Beating the Small Ords index — relative strength of 1.29, so it's outpacing the pack
●Trading above the 200-day average — the long-term trend is on your side
●Strong cash runway (9 quarters)

PEB Signals

●Volume surging at 19.8x normal while price falls — heavy selling pressure
●Trading above the 200-day average — the long-term trend is on your side
●Critical cash runway (1.0 quarters)
●Revenue in sharp decline (-46%)
●Piotroski F-Score weak (3/9, low-confidence approx)
●CANSLIM N: Near 52-week high (breakout territory)
●CANSLIM I: Institutional ownership (34%)
●Deeply negative margins (-275%)

Ask Scout AI to compare MSB and PEB in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
MSB Full Analysis → PEB Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).